Stay updated on Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page.

Latest updates to the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page
- Check4 days agoChange DetectedRevision label updated to v3.5.0; the previous v3.4.3 label has been removed.SummaryDifference0.0%

- Check11 days agoChange DetectedMelanoma is now listed as a related topic, and MedlinePlus Genetics is added to related topics. The site revision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedMelanoma topic tag and the related MedlinePlus Genetics topics have been removed from the page. This reduces disease-specific context and topic mapping for search and classification.SummaryDifference0.1%

- Check40 days agoChange DetectedMelanoma-related topics, related topic links, and a new Revision: v3.4.2 were added. An older revision note and a funding-status notice were removed.SummaryDifference0.5%

- Check47 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check54 days agoChange DetectedMinor UI and metadata changes: the glossary toggle is shown, the QC criteria label wording was adjusted, and the revision tag was updated from v3.3.4 to v3.4.0.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page.